Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have been diagnosed with a connective tissue disease (a condition where the immune system affects the body's connective tissues, such as joints, skin, and organs)
- People who have agreed to take part by signing an informed consent form
Who may not be able to join:
- People who have another serious health condition that affects or interferes with the progress of interstitial lung disease (a type of lung scarring or inflammation) or pulmonary hypertension (high blood pressure in the lungs) (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Judith Löffler-Ragg, Prof. MD, Medical University Innsbruck, Department Internal Medicine
Phone: +43 512-504-83765
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Decline in forced vital capacity; Increase in the modified Rodnan Skin Score; Decline in Diffusion capacity for carbon monoxide
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.